Hepatitis C: a concise review

Détails

ID Serval
serval:BIB_B27F31EB109A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Hepatitis C: a concise review
Périodique
Minerva Medica
Auteur(s)
Moradpour  D., Wolk  B., Cerny  A., Heim  M. H., Blum  H. E.
ISSN
0026-4806 (Print)
Statut éditorial
Publié
Date de publication
10/2001
Volume
92
Numéro
5
Pages
329-39
Notes
Comparative Study
Journal Article
Review --- Old month value: Oct
Résumé
Chronic hepatitis C is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Current treatment options are limited, but recent progress in the understanding of the molecular virology of hepatitis C has led to the identification of novel targets for antiviral intervention. In addition, gene and immunotherapeutic strategies to inhibit hepatitis C virus (HCV) replication or gene expression and to enhance the cellular immune response against HCV are being explored. These and other novel antiviral strategies may eventually complement existing therapeutic modalities. Here, we briefly review current concepts of the epidemiology, molecular virology, pathogenesis, natural history, diagnosis, therapy, and prevention of hepatitis C.
Mots-clé
Adult Aged Antiviral Agents/therapeutic use Child Clinical Trials Female Hepacivirus/immunology/isolation & purification *Hepatitis C, Chronic/diagnosis/drug therapy/immunology Humans Interferon-alpha/administration & dosage/therapeutic use Male Prognosis Ribavirin/therapeutic use Viral Vaccines/therapeutic use
Pubmed
Création de la notice
25/01/2008 16:06
Dernière modification de la notice
20/08/2019 15:21
Données d'usage